Literature DB >> 20961311

Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation.

Iurii Koboziev1, Fridrik Karlsson, Matthew B Grisham.   

Abstract

The etiologies of the inflammatory bowel diseases (IBD; Crohn's disease, ulcerative colitis) have not been fully elucidated. However, there is very good evidence implicating T cell and T cell trafficking to the gut and its associated lymphoid tissue as important components in disease pathogenesis. The objective of this review is to provide an overview of the mechanisms involved in naive and effector T cell trafficking to the gut-associated lymphoid tissue (GALT; Peyer's patches, isolated lymphoid follicles), mesenteric lymph nodes and intestine in response to commensal enteric antigens under physiological conditions as well as during the induction of chronic gut inflammation. In addition, recent data suggests that the GALT may not be required for enteric antigen-driven intestinal inflammation in certain mouse models of IBD. These new data suggest a possible paradigm shift in our understanding of how and where naive T cells become activated to yield disease-producing effector cells.
© 2010 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2010        PMID: 20961311      PMCID: PMC3075575          DOI: 10.1111/j.1749-6632.2010.05711.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  46 in total

1.  CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice.

Authors:  V Malmström; D Shipton; B Singh; A Al-Shamkhani; M J Puklavec; A N Barclay; F Powrie
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 2.  Anatomical basis of tolerance and immunity to intestinal antigens.

Authors:  Allan McI Mowat
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

3.  Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches.

Authors:  Thomas W Spahn; Hermann Herbst; Paul D Rennert; Norbert Lügering; Christian Maaser; Mathias Kraft; Adriano Fontana; Howard L Weiner; Wolfram Domschke; Torsten Kucharzik
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 4.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

5.  Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium.

Authors:  Robert A Bowden; Zhi-Ming Ding; Elizabeth M Donnachie; Thomas K Petersen; Lloyd H Michael; Christie M Ballantyne; Alan R Burns
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

6.  Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis.

Authors:  T Dohi; P D Rennert; K Fujihashi; H Kiyono; Y Shirai; Y I Kawamura; J L Browning; J R McGhee
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

7.  Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches.

Authors:  Thomas W Spahn; Howard L Weiner; Paul D Rennert; Norbert Lügering; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

8.  beta7 Integrin expression is not required for the localization of T cells to the intestine and colitis pathogenesis.

Authors:  B C Sydora; N Wagner; J Lohler; G Yakoub; M Kronenberg; W Muller; R Aranda
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 9.  Control of immune pathology by regulatory T cells.

Authors:  Fiona Powrie; Simon Read; Christian Mottet; Holm Uhlig; Kevin Maloy
Journal:  Novartis Found Symp       Date:  2003

Review 10.  Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition.

Authors:  P Rutgeerts; S Van Deventer; S Schreiber
Journal:  Aliment Pharmacol Ther       Date:  2003-06-15       Impact factor: 8.171

View more
  49 in total

Review 1.  The gastrointestinal immune system: Implications for the surgical patient.

Authors:  Joseph F Pierre; Rebecca A Busch; Kenneth A Kudsk
Journal:  Curr Probl Surg       Date:  2015-10-23       Impact factor: 1.909

Review 2.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

Review 3.  Heterogeneity across the murine small and large intestine.

Authors:  Rowann Bowcutt; Ruth Forman; Maria Glymenaki; Simon Richard Carding; Kathryn Jane Else; Sheena Margaret Cruickshank
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Proliferation and apoptosis of Peyer's patches and its lymphocytes in experimental terminal ileitis.

Authors:  Wei Wang; Ailei Xu; Guohua Zhou; Mingfang Leng; Hongyu Zhou; Jun Yan
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 5.  Evidence-Based Immunotherapeutic Effects of Herbal Compounds on Humoral Immunity: Ancient and New Approaches.

Authors:  Fatemeh Nejatbakhsh; Mohammad Ali Zareian; Mahdi Yaseliani; Hassan Abolhassani
Journal:  Chin J Integr Med       Date:  2021-03-24       Impact factor: 1.978

Review 6.  The gut microbiota--masters of host development and physiology.

Authors:  Felix Sommer; Fredrik Bäckhed
Journal:  Nat Rev Microbiol       Date:  2013-02-25       Impact factor: 60.633

7.  Empirical modeling of T cell activation predicts interplay of host cytokines and bacterial indole.

Authors:  Shelby Steinmeyer; Daniel P Howsmon; Robert C Alaniz; Juergen Hahn; Arul Jayaraman
Journal:  Biotechnol Bioeng       Date:  2017-07-27       Impact factor: 4.530

Review 8.  Immune responses triggering colitis and colitis-associated carcinoma.

Authors:  Rebecca Kesselring; Stefan Fichtner-Feigl
Journal:  Langenbecks Arch Surg       Date:  2012-03-01       Impact factor: 3.445

Review 9.  Protective and pro-inflammatory roles of intestinal bacteria.

Authors:  Cynthia Reinoso Webb; Iurii Koboziev; Kathryn L Furr; Matthew B Grisham
Journal:  Pathophysiology       Date:  2016-02-17

Review 10.  Rectal microbicide development.

Authors:  Ian McGowan; Charlene Dezzutti
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.